News >

Rapid Progress in HCC Leads to Sequencing Challenges

Kristi Rosa
Published: Sunday, Nov 10, 2019

Andreas Kaubisch, MD, an associate attending physician at Montefiore Medical Center and Albert Einstein College of Medicine

Andreas Kaubisch, MD

A slew of regulatory approvals for novel agents, such as TKIs and checkpoint inhibitors, has significantly advanced liver cancer treatment in recent years, according to Andreas Kaubisch, MD; however, with this rapid progress comes the challenge of learning how to best sequence these drugs in practice.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x